Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with NRSN: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
NRSN
NeuroSense Therapeutics Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
NRSN
NeuroSense Therapeutics Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
NRSN, dashed
LLY
ELI Lilly & Co
Change
1,386.26
▼
−2.24%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
NRSN
NeuroSense Therapeutics Ltd.
Change
1.38
▼
−2.82%
Regular session
Nov 5 '26
Mkt cap
$1.8M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 5 '26
LLY
ELI Lilly & Co
vs
NRSN
NeuroSense Therapeutics Ltd.
1,386.26
▼
−2.24%
Price
1.38
▼
−2.82%
$1.3T
Mkt cap
$1.8M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,386.26
▼
−2.24%
vs
NRSN
1.38
▼
−2.82%
Regular session
Nov 5 '26